LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article: Setting up and managing the Safe Haven Health Information Services. A health information manager's experience.

    Letizia, T

    Health information management : journal of the Health Information Management Association of Australia

    1999  Volume 29, Issue 3, Page(s) 131–132

    MeSH term(s) Australia ; Data Collection ; Hospital Information Systems ; Humans ; Information Management/organization & administration ; Medical Record Administrators ; Medical Records ; Refugees ; Yugoslavia/ethnology
    Language English
    Publishing date 1999
    Publishing country Australia
    Document type Journal Article
    ISSN 1322-4913
    ISSN 1322-4913
    DOI 10.1177/183335830002900313
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The role of klotho in systemic sclerosis.

    Talotta, R / Bongiovanni, S / Letizia, T / Rigamonti, F / Atzeni, F / Benucci, M / Vago, T / Sarzi-Puttini, P

    Reumatismo

    2017  Volume 69, Issue 4, Page(s) 156–163

    Abstract: The aim was to evaluate the role of klotho in the pathogenesis of systemic sclerosis (SSc), through the measurement of its serum concentration in SSc patients compared to healthy controls, and to assess the association with cutaneous and visceral ... ...

    Abstract The aim was to evaluate the role of klotho in the pathogenesis of systemic sclerosis (SSc), through the measurement of its serum concentration in SSc patients compared to healthy controls, and to assess the association with cutaneous and visceral involvement. Blood samples obtained from both SSc patients and healthy controls were analysed by an ELISA assay for the detection of human klotho. SSc patients were globally evaluated for disease activity and assessed through the modified Rodnan's Skin Score, Medsger's scale, pulmonary function tests, 2D-echocardiography, nailfold capillaroscopy and laboratory tests. Our cohort consisted of 69 SSc patients (61 females, mean age 64.5±12.5 years, median disease duration 9.0 (IQR 8) years) and 77 healthy controls (28 females, mean age 49.7±10.2 years). In the group of SSc patients, 19 (27.5%) suffered from a diffuse form of SSc. All patients were receiving IV prostanoids, and some of them were concomitantly treated with immunosuppressive drugs (prednisone, hydroxychloroquine, mofetil mycophenolate, methotrexate, cyclosporin A and azathioprine). The median serum concentration of klotho was significantly lower in patients compared to controls (0.23 ng/mL vs 0.60 ng/mL; p<0.001). However, Spearman's test showed no significant association between klotho serum levels and disease activity, concerning either clinical, laboratory or instrumental findings. Our data show a significant deficit of klotho in SSc patients although any significant association was detected between klotho serum concentration and the clinical, laboratory or instrumental features of the disease. However, due to the limits of the study, further investigations are required.
    MeSH term(s) Adult ; Aged ; Biomarkers ; Female ; Glucuronidase/blood ; Glucuronidase/physiology ; Humans ; Immunosuppressive Agents/therapeutic use ; Lung/pathology ; Male ; Microscopic Angioscopy ; Middle Aged ; Osteoporosis/etiology ; Prostaglandins/therapeutic use ; Scleroderma, Systemic/blood ; Scleroderma, Systemic/complications ; Scleroderma, Systemic/drug therapy ; Scleroderma, Systemic/pathology ; Statistics, Nonparametric
    Chemical Substances Biomarkers ; Immunosuppressive Agents ; Prostaglandins ; Glucuronidase (EC 3.2.1.31) ; klotho protein (EC 3.2.1.31)
    Language English
    Publishing date 2017-12-21
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 414816-2
    ISSN 2240-2683 ; 0048-7449
    ISSN (online) 2240-2683
    ISSN 0048-7449
    DOI 10.4081/reumatismo.2017.987
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis.

    Talotta, R / Rigamonti, F / Letizia, T / Bongiovanni, S / Ditto, M C / Antivalle, M / Santandrea, S / Atzeni, F / Vago, T / Sarzi-Puttini, P

    Reumatismo

    2019  Volume 71, Issue 1, Page(s) 19–23

    Abstract: Klotho is a transmembrane and soluble glycoprotein that governs vascular integrity. Previous studies have demonstrated reduced serum klotho concentrations in patients with systemic sclerosis (SSc), and it is known that klotho deficiency can impair the ... ...

    Abstract Klotho is a transmembrane and soluble glycoprotein that governs vascular integrity. Previous studies have demonstrated reduced serum klotho concentrations in patients with systemic sclerosis (SSc), and it is known that klotho deficiency can impair the healing of digital ulcers related to microvessel damage. The aim of this study was to evaluate the association between serum klotho levels and nailfold capillaroscopic abnormalities in SSc patients. We retrospectively enrolled 54 consecutive patients with SSc diagnosed on the basis of the 2013 EULAR/ACR criteria [11 with diffuse SSc; 47 females; median age 68.0 years (IQ 18); median disease duration 11.0 years (IQ 7)]. Serum klotho concentrations were determined by means of an enzyme-linked immunosorbent assay. On the basis of the 2000 classification of Cutolo et al., 14 patients had normal nailfold capillaroscopic findings, 8 had an early scleroderma pattern, 21 an active scleroderma pattern, and 11 a late scleroderma pattern. The median serum klotho concentration was 0.29 ng/mL (IQ 1). Regression analysis of variation showed an inverse correlation between serum klotho concentrations and the severity of the capillaroscopic pattern (p=0.02; t -2.2284), which was not influenced by concomitant treatment. Logistic regression did not reveal any significant association between the risk of developing digital ulcers and nailfold capillaroscopic patterns, serum klotho levels, or concomitant medications. The presence of avascular areas significantly correlated with calcinosis (p=0.006). In line with previous studies, our findings confirm that klotho plays a role in preventing microvascular damage detected with nailfold capillaroscopy.
    MeSH term(s) Adult ; Aged ; Antibodies, Antinuclear/blood ; Biomarkers/blood ; Calcinosis/complications ; Female ; Glucuronidase/blood ; Humans ; Male ; Microscopic Angioscopy ; Middle Aged ; Nail Diseases/blood ; Nail Diseases/etiology ; Nails/blood supply ; Regression Analysis ; Retrospective Studies ; Scleroderma, Systemic/blood ; Ulcer/etiology
    Chemical Substances Antibodies, Antinuclear ; Biomarkers ; Glucuronidase (EC 3.2.1.31) ; klotho protein (EC 3.2.1.31)
    Language English
    Publishing date 2019-04-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 414816-2
    ISSN 2240-2683 ; 0048-7449
    ISSN (online) 2240-2683
    ISSN 0048-7449
    DOI 10.4081/reumatismo.2019.1129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Placental ESRRG-CYP19A1

    Anelli, Gaia Maria / Mandò, Chiara / Letizia, Teresa / Mazzocco, Martina Ilaria / Novielli, Chiara / Lisso, Fabrizia / Personeni, Carlo / Vago, Tarcisio / Cetin, Irene

    Frontiers in pediatrics

    2019  Volume 7, Page(s) 154

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2019-04-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2019.00154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Sodium glucose cotransporters inhibitors in type 1 diabetes.

    Dellepiane, Sergio / Ben Nasr, Moufida / Assi, Emma / Usuelli, Vera / Letizia, Teresa / D'Addio, Francesca / Zuccotti, Gian Vincenzo / Fiorina, Paolo

    Pharmacological research

    2018  Volume 133, Page(s) 1–8

    Abstract: Sodium glucose cotransporter inhibitors (SGLTi) are oral hypoglycemic drugs that reduce renal glucose re-uptake and induce glycosuria. SGLTi have been successfully tested in large randomized clinical trials for type 2 diabetes, and several molecules have ...

    Abstract Sodium glucose cotransporter inhibitors (SGLTi) are oral hypoglycemic drugs that reduce renal glucose re-uptake and induce glycosuria. SGLTi have been successfully tested in large randomized clinical trials for type 2 diabetes, and several molecules have been approved in this setting by the international pharmaceutical agencies. Additionally, recent evidence has shown that SGLTi may be useful also in type 1 diabetes (T1D). Indeed, these drugs can be used as an ancillary to insulin to improve glycemic control and reduce insulin dosage, and such regimens have been associated with a lower rate of hypoglycemic episodes. The pharmacological effects of SGLTi therapy are described herein, and we also discuss the future use of SGLTi in T1D.
    MeSH term(s) Animals ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/metabolism ; Humans ; Hypoglycemic Agents/therapeutic use ; Sodium-Glucose Transport Proteins/antagonists & inhibitors ; Sodium-Glucose Transport Proteins/metabolism
    Chemical Substances Hypoglycemic Agents ; Sodium-Glucose Transport Proteins
    Language English
    Publishing date 2018-04-22
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 1003347-6
    ISSN 1096-1186 ; 0031-6989 ; 1043-6618
    ISSN (online) 1096-1186
    ISSN 0031-6989 ; 1043-6618
    DOI 10.1016/j.phrs.2018.04.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.

    Masson, S / Agabiti, N / Vago, T / Miceli, M / Mayer, F / Letizia, T / Wienhues-Thelen, U / Mureddu, G F / Davoli, M / Boccanelli, A / Latini, R

    Journal of internal medicine

    2015  Volume 277, Issue 3, Page(s) 318–330

    Abstract: Objectives: Fibroblast growth factor-23 (FGF-23) and vitamin D are hormones involved in phosphate homoeostasis. They also directly influence cardiomyocyte hypertrophy. We examined whether the relationships between levels of vitamin D or FGF-23, cardiac ... ...

    Abstract Objectives: Fibroblast growth factor-23 (FGF-23) and vitamin D are hormones involved in phosphate homoeostasis. They also directly influence cardiomyocyte hypertrophy. We examined whether the relationships between levels of vitamin D or FGF-23, cardiac phenotype and outcome were independent of established cardiac biomarkers in a large cohort of community-dwelling elderly subjects.
    Design and setting: Plasma levels of FGF-23 and vitamin D were measured in 1851 men and women (65-84 years) resident in the Lazio region of Italy. Participants were referred to eight cardiology centres for clinical examination, electrocardiography, comprehensive Doppler echocardiography and blood sampling. All-cause mortality or hospitalizations were available after a median follow-up of 47 months with record linkage of administrative data.
    Results: Vitamin D deficiency (<20 ng mL(-1) ) was found in 72.3% of subjects, but FGF-23 levels were normal [74 (58-97) RU per mL]. After adjustment for cardiovascular risk factors and morbidities, low concentrations of vitamin D and high levels of FGF-23 were associated with a higher left ventricular (LV) mass index. Levels of FGF-23 [hazard ratio (HR) (95% confidence interval (CI)) 1.71 (1.28-2.28), P < 0.0001] but not vitamin D [0.76 (0.57-1.01), P = 0.08] were independently associated with mortality after adjustment for clinical risk factors and two cardiac markers together (N-terminal pro-brain natriuretic peptide and high-sensitivity cardiac troponin T), but did not predict hospital admission. People with above median values of FGF-23 and below median values of vitamin D had greater LV hypertrophy and higher mortality.
    Conclusions: In community-dwelling elderly individuals with highly prevalent vitamin D deficiency, FGF-23 levels were associated with LV hypertrophy and predicted mortality independently of two robust cardiac biomarkers. A causal relationship was not demonstrated, but the hormones involved in mineral metabolism emerged as nontraditional risk factors and may affect cardiovascular risk.
    MeSH term(s) Aged ; Aged, 80 and over ; Biomarkers/metabolism ; Cross-Sectional Studies ; Female ; Fibroblast Growth Factors/metabolism ; Humans ; Hypertrophy, Left Ventricular/blood ; Hypertrophy, Left Ventricular/etiology ; Male ; Phenotype ; Prognosis ; Risk Factors ; Vitamin D/metabolism ; Vitamin D Deficiency/complications
    Chemical Substances Biomarkers ; fibroblast growth factor 23 ; Vitamin D (1406-16-2) ; Fibroblast Growth Factors (62031-54-3)
    Language English
    Publishing date 2015-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 96274-0
    ISSN 1365-2796 ; 0954-6820
    ISSN (online) 1365-2796
    ISSN 0954-6820
    DOI 10.1111/joim.12232
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Primary pulmonary arterial hypertension: Protocol to assess comprehensively in the rat the response to pharmacologic treatments.

    Novelli, Deborah / Fumagalli, Francesca / Staszewsky, Lidia / Ristagno, Giuseppe / Olivari, Davide / Masson, Serge / De Giorgio, Daria / Ceriani, Sabina / Massafra, Roberta / De Logu, Francesco / Nassini, Romina / Milioli, Marco / Facchinetti, Fabrizio / Cantoni, Silvia / Trevisani, Marcello / Letizia, Teresa / Russo, Ilaria / Salio, Monica / Latini, Roberto

    MethodsX

    2019  Volume 7, Page(s) 100771

    Abstract: The identification of new treatments for primary pulmonary arterial hypertension (PAH) is a critical unmet need since there is no a definitive cure for this disease yet. Due to the complexity of PAH, a wide set of methods are necessary to assess the ... ...

    Abstract The identification of new treatments for primary pulmonary arterial hypertension (PAH) is a critical unmet need since there is no a definitive cure for this disease yet. Due to the complexity of PAH, a wide set of methods are necessary to assess the response to a pharmacological intervention. Thus, a rigorous protocol is crucial when experimental studies are designed. In the present experimental protocol, a stepwise approach was followed in a monocrotaline-induced PAH model in the rat, moving from the dose finding study of treatment compounds to the recognition of the onset of disease manifestation, in order to identify when to start a curative treatment. A complete multidimensional evaluation of treatment effects represented the last step. The primary study endpoint was the change in right ventricular systolic pressure after 14 days of treatment; echocardiographic and biohumoral markers together with heart and pulmonary arterial morphometric parameters were considered as secondary efficacy and/or safety endpoints and for the evaluation of the biologic coherence in the different results.
    Language English
    Publishing date 2019-12-19
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2215-0161
    ISSN 2215-0161
    DOI 10.1016/j.mex.2019.100771
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.

    Novelli, Deborah / Fumagalli, Francesca / Staszewsky, Lidia / Ristagno, Giuseppe / Olivari, Davide / Masson, Serge / De Giorgio, Daria / Ceriani, Sabina / Affatato, Roberta / De Logu, Francesco / Nassini, Romina / Milioli, Marco / Facchinetti, Fabrizio / Cantoni, Silvia / Trevisani, Marcello / Letizia, Teresa / Russo, Ilaria / Salio, Monica / Latini, Roberto

    European journal of pharmacology

    2019  Volume 865, Page(s) 172777

    Abstract: Novel pharmacological approaches are needed to improve outcomes of patients with idiopathic pulmonary hypertension. Rho-associated protein kinase (ROCK) inhibitors have shown beneficial effects in preclinical models of pulmonary arterial hypertension ( ... ...

    Abstract Novel pharmacological approaches are needed to improve outcomes of patients with idiopathic pulmonary hypertension. Rho-associated protein kinase (ROCK) inhibitors have shown beneficial effects in preclinical models of pulmonary arterial hypertension (PAH), because of their role in the regulation of pulmonary artery vasoconstrictor tone and remodeling. We compared a ROCK inhibitor, Y-27632, for the first time with the dual endothelin receptor antagonist, macitentan, in a monocrotaline-induced rat pulmonary hypertension model. Different methods (echocardiography, hemodynamics, histology of right ventricle and pulmonary vessels, and circulating biomarkers) showed consistently that 100 mg/kg daily of Y-27632 and 10 mg/kg daily of macitentan slowed the progression of PAH both at the functional and structural levels. Treatments started on day 14 after monocrotaline injection and lasted 14 days. The findings of all experimental methods show that the selective ROCK inhibitor Y-27632 has more pronounced effects than macitentan, but a major limitation to its use is its marked peripheral vasodilating action.
    MeSH term(s) Amides/therapeutic use ; Animals ; Endothelin Receptor Antagonists/therapeutic use ; Heart Ventricles/pathology ; Hemodynamics/drug effects ; Hypertrophy, Right Ventricular/chemically induced ; Hypertrophy, Right Ventricular/drug therapy ; Male ; Monocrotaline ; Protein Kinase Inhibitors/therapeutic use ; Pulmonary Arterial Hypertension/chemically induced ; Pulmonary Arterial Hypertension/drug therapy ; Pulmonary Arterial Hypertension/pathology ; Pulmonary Artery/drug effects ; Pulmonary Artery/pathology ; Pyridines/therapeutic use ; Pyrimidines/therapeutic use ; Rats, Wistar ; Sulfonamides/therapeutic use ; rho-Associated Kinases/antagonists & inhibitors
    Chemical Substances Amides ; Endothelin Receptor Antagonists ; Protein Kinase Inhibitors ; Pyridines ; Pyrimidines ; Sulfonamides ; Y 27632 (138381-45-0) ; Monocrotaline (73077K8HYV) ; rho-Associated Kinases (EC 2.7.11.1) ; macitentan (Z9K9Y9WMVL)
    Language English
    Publishing date 2019-11-04
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2019.172777
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Measurement of Serum Klotho in Systemic Sclerosis.

    Talotta, Rossella / Bongiovanni, Sara / Letizia, Teresa / Rigamonti, Federica / Ditto, Maria Chiara / Atzeni, Fabiola / Salaffi, Fausto / Batticciotto, Alberto / Gerardi, Maria Chiara / Antivalle, Marco / Vago, Tarcisio / Benucci, Maurizio / Sarzi-Puttini, Piercarlo

    Disease markers

    2017  Volume 2017, Page(s) 9545930

    Abstract: Background: The aim of our study was to evaluate the serum concentration of klotho in a cohort of systemic sclerosis (SSc) patients compared to that of healthy controls and to correlate its levels with the degree and the kind of organ involvement.: ... ...

    Abstract Background: The aim of our study was to evaluate the serum concentration of klotho in a cohort of systemic sclerosis (SSc) patients compared to that of healthy controls and to correlate its levels with the degree and the kind of organ involvement.
    Methods: Blood samples obtained from both patients and controls were collected and analysed by an ELISA test for the determination of human soluble klotho. Scleroderma patients were evaluated for disease activity through clinical, laboratory, and instrumental assessment.
    Results: Our cohort consisted of 81 SSc patients (74 females, mean age 63.9 ± 13.1 years) and 136 healthy controls (78 females, mean age 50.5 ± 10.7 years). When matched for age, serum klotho concentration significantly differed between controls and patients (
    Conclusions: Our data show a lower concentration of klotho in the serum of SSc patients compared to that of healthy controls, without any significant association with clinical manifestations and laboratory and instrumental findings. The association between serum klotho and ACPA positivity requires further investigation.
    MeSH term(s) Adult ; Aged ; Biomarkers/blood ; Case-Control Studies ; Female ; Glucuronidase/blood ; Humans ; Male ; Middle Aged ; Scleroderma, Systemic/blood
    Chemical Substances Biomarkers ; Glucuronidase (EC 3.2.1.31) ; klotho protein (EC 3.2.1.31)
    Language English
    Publishing date 2017
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604951-5
    ISSN 1875-8630 ; 0278-0240
    ISSN (online) 1875-8630
    ISSN 0278-0240
    DOI 10.1155/2017/9545930
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Duration of Untreated Cardiac Arrest and Clinical Relevance of Animal Experiments: The Relationship Between the "No-Flow" Duration and the Severity of Post-Cardiac Arrest Syndrome in a Porcine Model.

    Babini, Giovanni / Grassi, Luigi / Russo, Ilaria / Novelli, Deborah / Boccardo, Antonio / Luciani, Anita / Fumagalli, Francesca / Staszewsky, Lidia / Fiordaliso, Fabio / De Maglie, Marcella / Salio, Monica / Zani, Davide D / Letizia, Teresa / Masson, Serge / Luini, Mario V / Pravettoni, Davide / Scanziani, Eugenio / Latini, Roberto / Ristagno, Giuseppe

    Shock (Augusta, Ga.)

    2017  Volume 49, Issue 2, Page(s) 205–212

    Abstract: Introduction: The study investigated the effect of untreated cardiac arrest (CA), that is, "no-flow" time, on postresuscitation myocardial and neurological injury, and survival in a pig model to identify an optimal duration that adequately reflects the ... ...

    Abstract Introduction: The study investigated the effect of untreated cardiac arrest (CA), that is, "no-flow" time, on postresuscitation myocardial and neurological injury, and survival in a pig model to identify an optimal duration that adequately reflects the most frequent clinical scenario.
    Methods: An established model of myocardial infarction followed by CA and cardiopulmonary resuscitation was used. Twenty-two pigs were subjected to three no-flow durations: short (8-10 min), intermediate (12-13 min), and long (14-15 min). Left ventricular ejection fraction (LVEF) was assessed together with thermodilution cardiac output (CO) and high sensitivity cardiac troponin T (hs-cTnT). Neurological impairment was evaluated by neurological scores, serum neuron specific enolase (NSE), and histopathology.
    Results: More than 60% of animals survived when the duration of CA was ≤13 min, compared to only 20% for a duration ≥14 min. Neuronal degeneration and neurological scores showed a trend toward a worse recovery for longer no-flow durations. No animals achieved a good neurological recovery for a no-flow ≥14 min, in comparison to a 56% for a duration ≤13 min (P = 0.043). Serum NSE levels significantly correlated with the no-flow duration (r = 0.892). Longer durations of CA were characterized by lower LVEF and CO compared to shorter durations (P < 0.05). The longer was the no-flow time, the higher was the number of defibrillations delivered (P = 0.043). The defibrillations delivered significantly correlated with LVEF and plasma hs-cTnT.
    Conclusions: Longer no-flow durations caused greater postresuscitation myocardial and neurological dysfunction and reduced survival. An untreated CA of 12-13 min may be an optimal choice for a clinically relevant model.
    MeSH term(s) Animals ; Cardiopulmonary Resuscitation ; Disease Models, Animal ; Heart Arrest/pathology ; Heart Arrest/therapy ; Male ; Swine
    Language English
    Publishing date 2017-05-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1185432-7
    ISSN 1540-0514 ; 1073-2322
    ISSN (online) 1540-0514
    ISSN 1073-2322
    DOI 10.1097/SHK.0000000000000914
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top